definiens: shall mean any and all of Novo Nordisk 's patents and patent applications possessed by Novo Nordisk prior to the Original Effective Date related to any Program Compound, including ( a ) patents and patent applications relating to the production, development and use of any Program Compound and ( b ) all continuations, continuations - in - part, divisionals or re - issues of such patents and patent applications and any patents issuing thereon or extensions thereof or any foreign counterparts thereof . Extensions of patents shall include : ( i ) extensions under the U.S. Patent Term Restoration Act, ( ii ) extensions under the Japanese Patent Law, ( iii ) Supplementary Protection Certificates for members of the European Patent Convention and other countries in the European 7 CERTAIN CONFIDENTIAl .. INFORMATION IN nils DOCUMENT, MARKED BY 8RACKETS . liAS BEEN OMITTED AND FlI .. EDSEPARATELY WITII nlE SECUAmES AND EXCUANGE COMMISSION PURSliANTTO Ruu : 24B-2 OF TIlE SECURlll£S ExCIIANGE ACT OF 1934, AS AMENDED . Economic Area and ( iv ) similar extensions under any applicable law in the Territory